Horizon Therapeutics - M&A Summary, Ownership, and Business Overview

Life ScienceCompany

Horizon Therapeutics M&A Summary

Horizon Therapeutics has acquired 12 companies of its own, including 3 in the last 5 years. A total of 4 acquisitions came from private equity firms. It has also divested 1 asset.

Horizon Therapeutics’ largest acquisition to date was in 2021, when it acquired Viela Bio for $3.1B. It’s largest disclosed sale occurred in 2017, when it sold Raptor Pharmaceuticals to Chiesi Farmaceutici for $70M. Horizon Therapeutics has acquired in 6 different US states, and 3 countries. The Company’s most targeted sectors include life science (100%).

Horizon Therapeutics Ownership

Who owns Horizon Therapeutics?

Horizon Therapeutics is owned by Amgen. It was acquired on December 12, 2022.

Horizon Therapeutics Business Overview

Where is Horizon Therapeutics headquartered?

Horizon Therapeutics is headquartered in Dublin, Ireland.

What is Horizon Therapeutics’ revenue?

Horizon Therapeutics disclosed revenue of 3,226M USD for 2021 and 2,200M USD for 2020.

How many employees does Horizon Therapeutics have?

Horizon Therapeutics has 2,100 employees.

What sector is Horizon Therapeutics in?

Horizon Therapeutics is a life science company.

When was Horizon Therapeutics founded?

Horizon Therapeutics was founded in 2005.

M&A Summary

  • M&A Total Activity12
    • M&A Buy Activity11
    • M&A Sell Activity1
  • Total Sectors Invested 1
  • Total Countries Invested 3
  • M&A Buy/Sell Connections 9
  • M&A Advisors 11

Horizon Therapeutics

Horizon Therapeutics Public Limited Company

70 Street Stephens Green,
Dublin, 2
Ireland,
353 1 772 2100
www.horizontherapeutics.com

Horizon Therapeutics is a biopharmaceutical company focused on improving patients’ lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs. The Company markets seven medicines through its orphan, primary care and specialty business units. Horizon Therapeutics was founded in 2005 and is based in Dublin, Ireland.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.6/yr) # 8 1 2 - - - 11
vol $3.3B $45M $3.1B $6.4B
Sell (0.0/yr) # 1 - - - - - 1
vol $70M $70M
  12

Most Recent M&A

Company Date Value Type
OPKO Health - Sterile Fill & Finish Manufacturing Facility 2021-06-17 65M USD Divestiture
Waterford, Ireland
Viela Bio, Inc. 2021-02-01 3.1B USD Add-on Acquisition
Gaithersburg, Maryland · www.vielabio.com
Curzion Pharmaceuticals, Inc. 2020-04-02 45M USD Add-on Acquisition
San Diego, California
Raptor Pharmaceuticals Corp. 2017-05-23 70M USD Divestiture
Novato, California · www.raptorpharma.com
River Vision Development Corp. 2017-05-08 145M USD Add-on Acquisition
New York, New York
Raptor Pharmaceuticals Corp. 2016-09-12 800M USD Add-on Acquisition
Novato, California · www.raptorpharma.com
Boehringer Ingelheim - Interferon Gamma-1b 2016-05-19 28M EUR Divestiture
, Germany
Crealta Pharmaceuticals, LLC 2015-12-11 510M USD Add-on Acquisition
Glendale, Wisconsin · www.crealtapharma.com
Hyperion Therapeutics, Inc. 2015-04-03 1.1B USD Add-on Acquisition
Brisbane, California · www.hyperiontx.com
Nuvo Research - PENNSAID 2014-10-17 45M USD Divestiture
, United States
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 11 (100%) 6.4B (100%) 1 (100%) 70M (100%)
Total 11 $6.4B 1 $70M

By Geo

State/Country Buy Value Sell Value
United States 9 6.4B 1 70M
  California 3 1.9B 1 70M
  Wisconsin 1 510M - -
  New York 1 145M - -
  Maryland 1 3.1B - -
  Georgia 1 660M - -
Germany 1 28M - -
Ireland 1 65M - -
Domestic 1 (9%) 65M (1%) - -
Cross-border 10 (91%) 6.4B (99%) 1 (100%) 70M (100%)
Total 11 $6.4B 1 $70M

Top M&A Advisors

Financial Deals
Citigroup Investment Banking
3
Jefferies
3
Cowen Group, Inc.
2
Legal Deals
Cooley
5
McCann FitzGerald
3
Skadden, Arps, Slate, Meagher & Flom
1

Deal Values

buy # Total
> $1B 2 $4.2B
$100M to $1B 4 $2.1B
< $100M 4 $183M
TOTAL $6.4B
Largest Viela Bio, Inc.
$3.1B (2021-02-01)
sell # Total
< $100M 1 $70M
TOTAL $70M
Largest Raptor Pharmaceuticals Corp.
$70M (2017-05-23)

M&A Connections

Deals
Acquired from
Investor(s)
27%
3 (27%)
Strategic(s)
36%
4 (36%)
Divested to
Strategic(s)
100%
1 (100%)

 Subscribe to unlock this and 204,418
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 196K M&A Transactions
  • 200K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 77K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for Horizon Therapeutics

Life Science Companies , Ireland Companies